Recruiting

Observational Study

Sponsor:

CorEvitas

Code:

NCT06100991

Conditions

Generalized Pustular Psoriasis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Conditions

Generalized Pustular Psoriasis

Study ID

NCT06100991

Start date

Sep 19, 2023

Status verified date

Aug, 2026

Completion date

Dec, 2099

Anticipated

Primary completion date

Dec, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • A subject must meet all the following criteria to participate in the registry:

1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
3. Is willing to provide consent for participation in the registry.
4. Is willing to provide Personal Information

Exclusion Criteria:

  • Any of the following would exclude the subject from participating in the registry:

1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.
2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Generalized Pustular Psoriasis (GPP)

Pts presenting to enrolling sites across the North America are invited to enroll if eligible

Primary outcome measure

  • Primary Outcome Measure:GPP epidemiology and Presentation [ Time Frame: Through study completion, an average of 10 years ]
  • GPP management, and outcomes [ Time Frame: Through study completion, an average of 10 years ]

Central Contacts and Locations

Central contacts

Generalized Pustular Psoriasis Registry Team

+1 508 408 5531ppd_corepsoriasis@thermofisher.com

Locations

CorEvitas, LLC

Recruiting

Waltham, Massachusetts, United States, 02451

Contacts

Generalized Pustular Psoriasis Registry Team

508-408-5531ppd_corepsoriasis@thermofisher.com

More Information

Sponsor

CorEvitas

Last update posted

Aug 26, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by CorEvitas on 2026-08-26.